Angeles Shunashy Galindo-Feria

Specialist in Rheumatology, MD, Ph.D,  

Karolinska Institutet, Karolinska University Hospital
Internal Medicine, Rheumatology specialist, Mexico, and Sweden.

My research focuses on the immunopathogenesis of idiopathic inflammatory myopathies (IIM), with a particular emphasis on the interplay between autoantibodies, autoreactive T cells, and HLA-associated genetic factors.

I am especially interested in the mechanisms driving necrotizing myopathies, including the anti-HMGCR and anti-FHL1 subgroups, and in identifying biomarkers that predict treatment response and disease progression.

A complementary line of my research investigates immune-related adverse events induced by immune checkpoint inhibitors, with a special focus on ICI-associated myositis, aiming to delineate shared and unique immune signatures across autoimmune and therapy-induced myopathies.

My current projects integrate single-cell and spatial transcriptomics, longitudinal immune profiling, and clinical phenotyping to develop personalized diagnostic and therapeutic strategies for patients with myositis.